BahVideo.com
Bovespa welcomes competition from BATS
Bovespa welcomes competition from BATS | BahVideo.com
Watch Bovespa welcomes competition from BATS

Bovespa welcomes competition from BATS

0 of 5 Stars
BM&F Bovespa accounts for over 80 per cent of Latin American trade in both derivatives and cash equities, but according to the Brazilian exchange’s UK representative Cathryn Lyall, the "Mila" alliance of the Colombia, Chile and Peru exchanges is not a threat but rather a boost to the region's attractiveness and liquidity. She also welcomes competition from BATS, but warns the opportunities are growing but still limited.
Channel: FT.com
Video Length: 333
Date Found: June 25, 2011
Category: Business
Date Produced:
View Count: 0
Flag
Related Videos
John Martin of Gilead plays long/short | BahVideo.com
FT.com

John Martin of Gilead plays long/short

0 of 5 Stars
July 15, 2011
John Martin, chief executive of Gilead, the US pharmaceuticals company behind flu and HIV drugs, places long or short bets on the news agenda from an HIV cure and Obama to US R&D and Google.
Technology is squeezing the middle | BahVideo.com
FT.com

Technology is squeezing the middle

0 of 5 Stars
July 15, 2011
The rich are getting richer but so are the poor. It is the workers in the middle who are feeling the pinch. Prof Alan Manning from the London School of Economics says technology is the main reason why middle ranking jobs are on the decline. However, he also thinks that banking regulations put ...
Lombard Odier’s credit 'niche' | BahVideo.com
FT.com

Lombard Odier’s credit 'niche'

0 of 5 Stars
July 15, 2011
Kevin Corrigan, head of credit at Lombard Odier Investment Managers, thinks there is an under-explored niche opportunity between investment grade and high yield bonds and that is why his company has launched its 5Bs fund. He says the risk characteristics of triple B and double B rated bonds are ...
Patent pools key to cheaper generic drugs | BahVideo.com
FT.com

Patent pools key to cheaper generic drugs

0 of 5 Stars
July 15, 2011
Gilead was founded 30 years ago and now the biotech start-up has become a leading US pharmaceutical company behind flu and HIV treatments, Tamiflu and Atripla. Pharmaceuticals correspondent Andrew Jack assesses chief executive John Martin’s views on drug access for poorer countries, innovation ...
Patent pools key to cheaper generic drugs | BahVideo.com
FT.com

Patent pools key to cheaper generic drugs

0 of 5 Stars
July 15, 2011
Gilead was founded 30 years ago and now the biotech start-up has become a leading US pharmaceutical company behind flu and HIV treatments, Tamiflu and Atripla. Pharmaceuticals correspondent Andrew Jack assesses chief executive John Martin’s views on drug access for poorer countries, innovation ...
: advertisement :
Featured
Content
Featuring websites that enhance the internet user’s experience.

Like
Like